Seroprevalence of tetanus antibodies among pregnant women in Duhok Governorate, Iraq

Maternal and Child Health Care Section, Department of Preventive Health, Duhok General Directorate of Health, Duhok, Iraq.
Eastern Mediterranean health journal = La revue de santé de la Méditerranée orientale = al-Majallah al-ṣiḥḥīyah li-sharq al-mutawassiṭ 06/2012; 18(6):573-8.
Source: PubMed


Maternal immunization with tetanus toxoid (TT) is the most effective was to prevent neonatal tetanus. In Duhok, Iraq data indicate low vaccination coverage. This study assessed TT immunization status among 600 randomly selected pregnant women attending Azadi teaching hospital, Duhok for delivery, by both tetanus antibody seroprevalence and TT history. WHO criteria for protective levels were used for seroprevalence and vaccination history. Overall, 90% of the women at delivery had protective tetanus antitoxin titres compared to only 55% considered protected according to their vaccination history. Immunity rates for women who had received no TT vaccination, 1 dose, 2 doses and > or = 3 doses were 28.0%, 92.6%, 100.0% and 99.0% respectively. Groups with lower serological immunity levels were women aged less than 25 years, those reporting no history of vaccination and those living in Akre, Bardarash or Shekhan districts of Duhok. Tetanus immunity determined by seroprevalence of tetanus antitoxin levels exceeded that estimated by vaccination history, and serological markers should be used instead of vaccination history in determining immunity status.

5 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Serologic data on diseases that are preventable by vaccine are useful to evaluate the success of immunization programs and to identify susceptible subgroups. To provide national estimates of immunity to diphtheria and tetanus by measurement of serum antibody levels. Examination of data from the Third National Health and Nutrition Examination Survey, a representative cross-sectional sample of the U.S. population. 89 randomly selected locations throughout the United States. 18 045 persons 6 years of age or older who were examined from 1988 to 1994. Serum samples obtained at a single time point were tested for diphtheria and tetanus antitoxin. Overall, 60.5% of Americans 6 years of age or older had fully protective levels of diphtheria antibody (> or =0.10 IU/mL) and 72.3% had protective levels of tetanus antibody (> 0.15 IU/mL). Ninety-one percent of Americans 6 to 11 years of age had protective levels of both diphtheria and tetanus antibody; this proportion decreased to approximately 30% among persons 70 years of age (29.5% for diphtheria and 31.0% for tetanus). Adult Mexican-Americans were slightly less likely to have protective levels of antibody to both toxins. Only 47% of persons 20 years of age or older had levels that were protective against both diseases, and only 63% of adults who were protected against tetanus were also protected against diphtheria. A substantial proportion of adults in the United States do not have antibody levels that are protective against diphtheria and tetanus. In addition, although the recommended vaccine is a combination of tetanus and diphtheria, only 63% of adults with protective antibody to tetanus also had protective antibody to diphtheria.
    Annals of internal medicine 05/2002; 136(9):660-6. DOI:10.7326/0003-4819-136-9-200205070-00008 · 17.81 Impact Factor
  • Source
    01/2007; World Health Organization, Geneva.
  • The Nurse Practitioner 02/2003; 28(2). DOI:10.1097/00006205-200302000-00013


5 Reads